MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss and
comprehensive loss
-$1,279K
Operating loss
-$1,245K
Total financial
expense, net
-$34K
Research and development
expenses
$631K
General and
administrative expenses
$614K
Back
Back
Income Statement
source: myfinsight.com
Raphael Pharmaceutical Inc. (RAPH)
Raphael Pharmaceutical Inc. (RAPH)